Health & Life Co., Ltd. (1781.TWO)
TWD 17.45
(-0.57%)
TWD 17.45
(-0.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 84.91 Million | -80.69 Million | -131.15 Million | -34.35 Million | - |
| Net Income | -37.56 Million | -15.46 Million | -83.3 Million | 264.51 Million | - |
| Depreciation & Amortization | 24.44 Million | 24.17 Million | 17.16 Million | 11.87 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 97.39 Million | -68.9 Million | -59.89 Million | -27.51 Million | - |
| Other non-cash items | 3.01 Million | 2.27 Million | 1.13 Million | 2.15 Million | - |
| Investing Cash Flow | -8.78 Million | -10.31 Million | -16.02 Million | 229.02 Million | - |
| Investments in PPE | -8.09 Million | -12.32 Million | -13.89 Million | -34.09 Million | - |
| Acquisitions | 321 Thousand | - | - | 329.14 Million | - |
| Investment purchases | -1.05 Million | - | - | -1.59 Million | - |
| Sales/Maturities of investments | - | - | 1.29 Million | - | - |
| Other Investing Activities | 39 Thousand | -126 Thousand | -3.42 Million | -65.5 Million | - |
| Financing Cash Flow | -74.66 Million | 25.9 Million | -91.1 Million | 75.77 Million | - |
| Debt repayment | -62.91 Million | -38.95 Million | -81.41 Million | -74.75 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -7000.00 | 7000.00 | -32 Thousand | 428 Thousand | - |
| Accounts receivables | 35.74 Million | - | - | - | - |
| Accounts payables | 24.53 Million | - | - | - | - |
| Inventory | 29.17 Million | 421 Thousand | -41.57 Million | -241.1 Million | - |
| Other working capital | 32.47 Million | - | - | - | - |
| Cash at beginning of period | 156.64 Million | 200.01 Million | 433.25 Million | 141.44 Million | - |
| Cash at end of period | 150.71 Million | 156.64 Million | 200.01 Million | 433.25 Million | - |
| Capital Expenditure | -8.09 Million | -12.32 Million | -13.89 Million | -34.09 Million | - |
| Effect of forex changes on cash | -7.38 Million | 21.73 Million | 5.03 Million | 21.37 Million | - |
| Net cash flow / Change in cash | -5.92 Million | -43.37 Million | -233.24 Million | 291.81 Million | - |
| Free Cash Flow | 76.81 Million | -93.01 Million | -145.04 Million | -68.45 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.66 Million | 16.29 Million | -31.37 Million | -37.56 Million | 27.72 Million | -18.65 Million |
| Depreciation & Amortization | 6.22 Million | 6.35 Million | 6.29 Million | 24.44 Million | 6.38 Million | 6.17 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -12 Million | -14.56 Million | 31.66 Million | 97.39 Million | 13.47 Million | 71.29 Million |
| Other non-cash items | -29 Thousand | 4000.00 | -134 Thousand | 3.01 Million | 852 Thousand | 895 Thousand |
| Investing Cash Flow | -2.38 Million | -310 Thousand | -2.52 Million | -8.78 Million | -3.47 Million | 1.34 Million |
| Investments in PPE | -2.13 Million | -525 Thousand | -1.83 Million | -8.09 Million | -3.42 Million | -1.33 Million |
| Acquisitions | -250 Thousand | - | - | - | - | - |
| Investment purchases | 6000.00 | -6000.00 | - | -1.05 Million | - | 2.62 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -8000.00 | -29 Thousand | 153 Thousand | 39 Thousand | -51 Thousand | -57 Thousand |
| Financing Cash Flow | -6.26 Million | -6.14 Million | -37.67 Million | -74.66 Million | -5.31 Million | -25.51 Million |
| Debt repayment | -3.15 Million | -3.15 Million | -34.64 Million | -62.91 Million | -2.58 Million | -22.52 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -16 Thousand | 26 Thousand | -14 Thousand | -7000.00 | 17 Thousand | -12 Thousand |
| Accounts receivables | -8.36 Million | - | - | - | - | - |
| Accounts payables | 10.42 Million | - | - | - | - | - |
| Inventory | -11.75 Million | 66.59 Million | -58.81 Million | 29.17 Million | 39.61 Million | 16.8 Million |
| Other working capital | -5.33 Million | - | - | - | - | - |
| Cash at beginning of period | 150.22 Million | 150.71 Million | 190.43 Million | 156.64 Million | 154.62 Million | 116.74 Million |
| Cash at end of period | 121.4 Million | 150.22 Million | 150.71 Million | 150.71 Million | 190.43 Million | 154.62 Million |
| Capital Expenditure | -2.13 Million | -525 Thousand | -1.83 Million | -8.09 Million | -3.42 Million | -1.33 Million |
| Effect of forex changes on cash | -4.02 Million | 4.47 Million | -21.74 Million | -7.38 Million | 9.19 Million | 5.14 Million |
| Net cash flow / Change in cash | -28.81 Million | -497 Thousand | -39.71 Million | -5.92 Million | 35.81 Million | 37.87 Million |
| Free Cash Flow | -18.27 Million | 959 Thousand | 20.38 Million | 76.81 Million | 31.98 Million | 55.56 Million |
6092
CRW
0315
FRSB
CEBCF
RAYT